These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 15861713)
1. [Clinical application of NKT cell system for lung cancer]. Motohashi S Nihon Rinsho; 2005 Apr; 63 Suppl 4():574-8. PubMed ID: 15861713 [No Abstract] [Full Text] [Related]
2. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients. Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688 [TBL] [Abstract][Full Text] [Related]
3. The immunoregulatory role of CD1d-restricted natural killer T cells in disease. van der Vliet HJ; Molling JW; von Blomberg BM; Nishi N; Kölgen W; van den Eertwegh AJ; Pinedo HM; Giaccone G; Scheper RJ Clin Immunol; 2004 Jul; 112(1):8-23. PubMed ID: 15207777 [TBL] [Abstract][Full Text] [Related]
4. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells. Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291 [TBL] [Abstract][Full Text] [Related]
5. beta-Glycosphingolipids as immune modulators. Adar T; Ilan Y J Immunotoxicol; 2008 Apr; 5(2):209-20. PubMed ID: 18569392 [TBL] [Abstract][Full Text] [Related]
6. [A specific ligand of V alpha 14 NKT cells and its presentation]. Harada M; Taniguchi M Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1126-32. PubMed ID: 12807019 [No Abstract] [Full Text] [Related]
7. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice. Cardell SL Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042 [TBL] [Abstract][Full Text] [Related]
8. Application of natural killer T cells in antitumor immunotherapy. Hong C; Park SH Crit Rev Immunol; 2007; 27(6):511-25. PubMed ID: 18197797 [TBL] [Abstract][Full Text] [Related]
9. Decreased expressions of CD1d molecule on liver dendritic cells in subcutaneous tumor bearing mice. Tatsumi T; Takehara T; Yamaguchi S; Sasakawa A; Yamamoto M; Fujita Y; Miyagi T; Ohkawa K; Hayashi N J Hepatol; 2008 Nov; 49(5):779-86. PubMed ID: 18760855 [TBL] [Abstract][Full Text] [Related]
10. A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. Ishikawa A; Motohashi S; Ishikawa E; Fuchida H; Higashino K; Otsuji M; Iizasa T; Nakayama T; Taniguchi M; Fujisawa T Clin Cancer Res; 2005 Mar; 11(5):1910-7. PubMed ID: 15756017 [TBL] [Abstract][Full Text] [Related]
11. Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway. Delcayre A; Shu H; Le Pecq JB Expert Rev Anticancer Ther; 2005 Jun; 5(3):537-47. PubMed ID: 16001959 [TBL] [Abstract][Full Text] [Related]
13. Natural killer T cell-mediated antitumor immune responses and their clinical applications. Seino K; Motohashi S; Fujisawa T; Nakayama T; Taniguchi M Cancer Sci; 2006 Sep; 97(9):807-12. PubMed ID: 16805854 [TBL] [Abstract][Full Text] [Related]
14. Mediastinal lymph node CD8alpha- DC initiate antigen presentation following intranasal coadministration of alpha-GalCer. Ko SY; Lee KA; Youn HJ; Kim YJ; Ko HJ; Heo TH; Kweon MN; Kang CY Eur J Immunol; 2007 Aug; 37(8):2127-37. PubMed ID: 17615581 [TBL] [Abstract][Full Text] [Related]
15. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005 [TBL] [Abstract][Full Text] [Related]
16. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4. Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507 [TBL] [Abstract][Full Text] [Related]
17. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity. Mannoor MK; Weerasinghe A; Halder RC; Reza S; Morshed M; Ariyasinghe A; Watanabe H; Sekikawa H; Abo T Cell Immunol; 2001 Aug; 211(2):96-104. PubMed ID: 11591113 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of early tumor growth requires J alpha 18-positive (natural killer T) cells. Stewart TJ; Smyth MJ; Fernando GJ; Frazer IH; Leggatt GR Cancer Res; 2003 Jun; 63(12):3058-60. PubMed ID: 12810627 [TBL] [Abstract][Full Text] [Related]
19. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254 [TBL] [Abstract][Full Text] [Related]